LINDSAY MABE: Open Payments
NPI 1437696606 · LIVINGSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$778 in 43 payments from 20 companies in 2025. Trend: 2023 $665 · 2024 $749 · 2025 $778
Food & beverage: $778
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 5 | $80 |
| Lilly USA, LLC | 5 | $77 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $73 |
| Novo Nordisk Inc | 4 | $72 |
| ABBVIE INC. | 3 | $62 |
| Viatris Specialty LLC | 2 | $58 |
| Amgen Inc. | 3 | $50 |
| Dexcom, Inc. | 2 | $50 |
| Esperion Therapeutics, Inc. | 2 | $37 |
| Kowa Pharmaceuticals America, Inc. | 2 | $35 |
Products named: Kerendia, The Cologuard Plus Collection Kit, MOUNJARO, YUPELRI, Dexcom G6 Transmitter, UBRELVY, Ozempic, NEXLETOL.
Industry payments across TX — which companies pay providers there.
